Cited by 203Radiopharmaceutical Chemistry and ApplicationsChemical Reactions and IsotopesRadioactivity and Radon Measurements

The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.

Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

Open access

Robertson, Andrew Kyle Henderson, Ramogida, Caterina Fortunata, Schaffer, Paul, Radchenko, Valery·2018·Current Radiopharmaceuticals

DOI 10.2174/1874471011666180416161908PMC PMC6249690

Open this paper in CoChat — free account

Abstract

BACKGROUND: The development of radiopharmaceuticals containing 225Ac for targeted alpha therapy is an active area of academic and commercial research worldwide. OBJECTIVES: Despite promising results from recent clinical trials, 225Ac-radiopharmaceutical development still faces significant challenges that must be overcome to realize the widespread clinical use of 225Ac. Some of these challenges include the limited availability of the isotope, the challenging chemistry required to isolate 225Ac from any co-produced isotopes, and the need for stable targeting systems with high radiolabeling yields. RESULTS: Here we provide a review of available literature pertaining to these challenges in the 225Acradiopharmaceutical field and also provide insight into how performed and planned efforts at TRIUMF - Canada's particle accelerator centre - aim to address these issues.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2174/1874471011666180416161908

Cites

59 of 59 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
Kratochwil, C., Bruchertseifer, F., Giesel, F. L., Weis, M., Verburg, F. A., Mottaghy, F. M., Kopka, K., Apostolidis, C., Haberkorn, U., & Morgenstern, A. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.178673 · Cited by 1,187
Matching chelators to radiometals for radiopharmaceuticals
Price, E. W., & Orvig, C. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60304k · Cited by 1,064
MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy
Sgouros, G., Roeske, J. C., McDevitt, M. R., Palm, S., Allen, B. J., Fisher, D. R., Brill, A. B., Song, H., Howell, R. W., & Akabani, G. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.058651 · Cited by 552
Tumor therapy with targeted atomic nanogenerators.
McDevitt, M. R., Ma, D., Lai, L. T., Simon, J., Borchardt, P., Frank, R. K., Wu, K., Pellegrini, V., Curcio, M. J., Miederer, M., et al. (2001) · Science · doi:10.1126/science.1064126 · Cited by 501
213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
Kratochwil, C., Giesel, F. L., Bruchertseifer, F., Mier, W., Apostolidis, C., Boll, R. A., Murphy, K., Haberkorn, U., & Morgenstern, A. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2857-9 · Cited by 418
Radioimmunotherapy with alpha-emitting nuclides
McDevitt, M. R., Sgouros, G., Finn, R. D., Humm, J. L., Jurcic, J. G., Larson, S. M., & Scheinberg, D. A. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050306 · Cited by 403
An overview of targeted alpha therapy
Kim, Y., & Brechbiel, M. W. (2011) · Tumor Biology · doi:10.1007/s13277-011-0286-y · Cited by 280
Tumour targeting with radiometals for diagnosis and therapy
Ramogida, C. F., & Orvig, C. (2013) · Chemical Communications · doi:10.1039/c3cc41554f · Cited by 268
Self-citation
A Critical Review of Alpha Radionuclide Therapy—How to Deal with Recoiling Daughters?
de Kruijff, R. M., Wolterbeek, H. T., & Denkova, A. G. (2015) · Pharmaceuticals · doi:10.3390/ph8020321 · Cited by 254
Design and synthesis of 225Ac radioimmunopharmaceuticals.
McDevitt, M. R., Ma, D., Simon, J., Frank, R. K., & Scheinberg, D. A. (2002) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(02)00167-7 · Cited by 225

Flagged first, then by citations

Show all 59 references

Research works printed but not linked: 5

[26]Dilling J. Kreuken R. Merminga L. ISAC and ARIEL: The TRIUMF Radioactive Beam Facilities and the Scientific Program. Springer 2014
[35]Stacey M.W. Nuclear Reactor Physics. 2nd ed Weinheim, Germany Wiley-VCH 2007
[41]Lesrel J. Arianer J. Arianer M. Bajeat O. Buhour J-m. Byzl H. Carrey F. Chabot M. Corbin T. Croizet H. Curaudeau J. Doizon F. Ducourtieu M. Dufour J-m. Grialou D. Joly C. Kaminski M. Lefort H. Lesellier B. Magneney G. Mottet L. Planat C. Raynaud M. Richard Y. Said A. Semsoum A. Taquin F. Vogel C. Bienvenu G. Cayla J-n. Lal M.D. Commissioning of the Alto 50 MeV Electron Linac. Proc. EPAC 2006 2006 3 5
[47]Jost C.U. Griswold J.R. Bruffey S.H. Mirzadeh S. Stracener D.W. Williams C.L. Measurement of cross sections for the 232Th(P,4n) 229Pa reaction at low proton energies. AIP Conf. Proc. 2013 1525 520 524
[71]Merminga L. Ames F. Baartman R. Bricault P. Bylinski Y. Chao Y.C. Dawson R. Kaltchev D. Koscielniak S. Laxdal R. Mammarella F. Marchetto M. Minor G. Mitra A. Rao Y.N. Trinczek M. Trudel A. Verzilov V. Zvyagintsev V. ariel: triumf’s advanced rare isotope laboratory. Proceedings of 2011 IPAC2011 1917 1919

Sorted by citations

Items 101–200 of 203

Recommendations on the Clinical Application and Future Potential of α-Particle Therapy: A Comprehensive Review of the Results from the SECURE Project
Iorio, V. D., Sarnelli, A., Boschi, S., Sansovini, M., Genovese, R. M., Ştefănescu, C., Ghizdovăţ, V., Jalloul, W., Young, J. D., Sosabowski, J. K., et al. (2025) · Pharmaceuticals · doi:10.3390/ph18101578 · Cited by 10
Regulating alpha-emitting radioisotopes and specific considerations for actinium-225 containing actinium-227
Shober, M. (2022) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2022.110337 · Cited by 9
225 Ac/ 213 Bi radionuclide generators for the separation of 213 Bi towards clinical demands
Zhu, H., Heinitz, S., Binnemans, K., Mullens, S., & Cardinaels, T. (2024) · Inorganic Chemistry Frontiers · doi:10.1039/d4qi00326h · Cited by 9
Preclinical evaluation of 225Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha Therapy
Holzleitner, N., Vilangattil, M. M., Swaidan, A., Garcia-Prada, C. D., Taddio, M. F., Jeanjean, P., Mona, C. E., Lapa, C., Casini, A., Günther, T., et al. (2024) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-024-06927-z · Cited by 11
Separation of thorium from uranium ore
Kmak, K. N., Shaughnessy, D. A., & Vujic, J. L. (2019) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-019-06980-1 · Cited by 9
Current role of prostate-specific membrane antigen-based imaging and radioligand therapy in castration-resistant prostate cancer
Chen, J., Qi, L., Tang, Y., Tang, G., Gan, Y., & Cai, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.958180 · Cited by 9
Radioactive Metals in Imaging and Therapy
Rivas, C., Jackson, J. A., Hungnes, I. N., & Ma, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-08-102688-5.00010-6 · Cited by 8
Design and Radiological Study of the 225ac Medical Target at the Triumf-Ariel Proton-Target Station
Augusto, R. D. S., Smith, J., Varah, S., Paley, W., Egoriti, L., McEwen, S., Goodacre, T. D., Mildenberger, J., Gottberg, A., Trudel, A. J., et al. (2022) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2022.110491 · Cited by 8
Modern Alchemy to Fight Cancer
Radchenko, V., & Hoehr, C. (2020) · Nuclear Physics News · doi:10.1080/10619127.2020.1752101 · Cited by 8
Self-citation
Clinical Image-Based Dosimetry of Actinium-225 in Targeted Alpha Therapy
Ramonaheng, K., Banda, K., Qebetu, M., Goorhoo, P., Legodi, K., Masogo, T., Seebarruth, Y., Mdanda, S., Sibiya, S. M., Mzizi, Y. V., et al. (2026) · Cancers · doi:10.3390/cancers18020321 · Cited by 8
Evaluation of a Radio-IMmunoStimulant (RIMS) in a Syngeneic Model of Murine Prostate Cancer and ImmunoPET Analysis of T-cell Distribution
Śmiłowicz, D., Schlyer, D. J., Boros, E., & Meimetis, L. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00361 · Cited by 7
Development of an actinium-225 radioimmunoconjugate for targeted alpha therapy against SARS-CoV-2
Pallares, R. M., Flick, M., Shield, K. M., Bailey, T. A., Velappan, N., Lillo, A. M., & Abergel, R. J. (2022) · New Journal of Chemistry · doi:10.1039/d2nj02617a · Cited by 7
A Consensus Time for Performing Quality Control of 225Ac-Labeled Radiopharmaceuticals
Kelly, J. M., Amor-Coarasa, A., Sweeney, E., Wilson, J. J., Causey, P. W., & Babich, J. (2021) · doi:10.21203/rs.3.rs-39342/v2 · Cited by 11
Cross sections of the 226Ra(p,xn) reactions relevant for 225Ac production
Lebeda, O., Fialová, K. O., Ondrák, L., Červenák, J., Ráliš, J., & Štursa, J. (2025) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2025.108995 · Cited by 6
Measurement of 232Th(p, x)225Ac reaction cross section at CSNS APEP facility up to 80 MeV
Jiang, B., Tian, B., Jing, H., Dong, Q., & Guo, L. (2025) · Nuclear Science and Techniques · doi:10.1007/s41365-024-01616-w · Cited by 6
Photonuclear production of 225Ac from 226Ra targets
Diehl, G., Holschuh, T., Foley, A. A., Meiers, J. L., Brookhart, J., Cooper, J. T., Stoner, J., Carney, K., Mastren, T., & Snow, M. S. (2025) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-025-10328-3 · Cited by 6
Alpha Particle Emitter Radiolabeled Antibodies in Cancer Therapy: Current Status, Challenges, and Future Prospects
Palangka, C. R. A. P., Mahendra, I., Ritawidya, R., Kondo, N., & Nakajima, T. (2025) · Pharmaceuticals · doi:10.3390/ph18091316 · Cited by 6
Targeted alpha therapy (r)evolution: emerging nuclides for clinical applications
Pedersen, N. B., Straathof, N. J. W., Elvas, F., Herth, M. M., & Battisti, U. M. (2026) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2026.01.001 · Cited by 6
The role of chemistry in accelerator-based production and separation of radionuclides as basis for radiolabelled compounds for medical applications
Qaim, S. M., Spahn, I., Scholten, B., Spellerberg, S., & Neumaier, B. (2022) · Radiochimica Acta · doi:10.1515/ract-2022-0017 · Cited by 6
Radium separation from thorium and manufacturing of targets by precipitation method
Yin, F., Fukutani, S., Toyama, M., YAMAMURA, T., & Suzuki, T. (2024) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-024-09496-5 · Cited by 6
Transport cocktails for cancer therapeutics
Kavousanakis, M. E., Bhatavdekar, O., Bastiaannet, R., Kevrekidis, I. G., & Sofou, S. (2024) · Physical Review Research · doi:10.1103/physrevresearch.6.033137 · Cited by 6
Somatostatin receptor‐linked α‐particle therapy in neuroendocrine tumours
Navalkissoor, S., & Grossman, A. B. (2024) · Journal of Neuroendocrinology · doi:10.1111/jne.13463 · Cited by 6
Production and purification of molecular 225Ac at CERN-ISOLDE
Au, M., Nies, L., Stegemann, S., Athanasakis-Kaklamanakis, M., Cocolios, T. E., Fischer, P., Giesel, P. F., Johnson, J. D., Köster, U., Lange, D., et al. (2024) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-024-09811-0 · Cited by 8
Monte Carlo dosimetry of a realistic multicellular model of follicular lymphoma in a context of radioimmunotherapy
Bordes, J., Incerti, S., Mora‐Ramirez, E., Tranel, J., Rossi, C., Bezombes, C., Bordenave, J., Bardiès, M., Brown, R., & Bordage, M. (2020) · Medical Physics · doi:10.1002/mp.14370 · Cited by 6
An overview of the shielding optimization studies for the TRIUMF-ARIEL facility
Augusto, R. D. S., Trudel, A. J., Liu, Z., Kinakin, M., Paley, W., Bjelić, Z., Messenberg, A., Mildenberger, J., Chak, J., Groumoutis, T., et al. (2021) · Nuclear Instruments and Methods in Physics Research Section A Accelerators Spectrometers Detectors and Associated Equipment · doi:10.1016/j.nima.2021.165401 · Cited by 6
Quantification of trace 227Ac and other radionuclidic impurities in mass-separated 225Ac samples produced at CERN-MEDICIS
Johnson, J. D., Bernerd, C., Bruchertseifer, F., Cocolios, T. E., Deseyn, M., Duchemin, C., Heines, M., Keppens, M., Lambert, L., Meurrens, N., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-02277-4 · Cited by 5
Solvent extraction of Ac-225 in nano-layer coated, solvent resistant PDMS microfluidic chips
Trapp, S., Santoso, A., Hounat, Y., Paulßen, E., van Ommen, J. R., van Steijn, V., & de Kruijff, R. M. (2024) · Scientific Reports · doi:10.1038/s41598-024-81177-5 · Cited by 5
Production of radionuclides: Cyclotrons and reactors
Benešová, M., & Reischl, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822960-6.00003-x · Cited by 5
Production study of Fr, Ra and Ac radioactive ion beams at ISOLDE, CERN
Jajčišinová, E., Dockx, K., Au, M., Bara, S., Cocolios, T. E., Chrysalidis, K., Farooq-Smith, G. J., Федоров, Д. В., Fedosseev, V. N., Flanagan, K. T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-60331-z · Cited by 5
Chelator-impregnated polydimethylsiloxane beads for the separation of medical radionuclides
Santoso, A., Trapp, S., Blommestein, I. M. S., Saedy, S., van Ommen, J. R., de Kruijff, R. M., & van Steijn, V. (2024) · Separation and Purification Technology · doi:10.1016/j.seppur.2024.128865 · Cited by 5
Design of a compact shielding envelope and elements of radiological protection at the TRIUMF-ARIEL facility
Trudel, A. J., Augusto, R. D. S., Liu, Z., Kinakin, M., Mildenberger, J., Gottberg, A., Paley, W., Minor, G., Messenberg, A., Bjelić, Z., et al. (2019) · Radiation Physics and Chemistry · doi:10.1016/j.radphyschem.2019.108640 · Cited by 5
Pr(H3BNMe2BH3)3 and Pr(thd)3 as Volatile Carriers for Actinium-225. Deposition of Actinium-Doped Praseodymium Boride Thin Films for Potential Use in Brachytherapy
Daly, S. R., Bellott, B. J., McAlister, D. R., Horwitz, E. P., & Girolami, G. S. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c00442 · Cited by 5
PSMA radioligand therapy in prostate cancer: overview, latest advances and remaining challenges
Sachpekidis, C., Alberts, I., Rominger, A., & Afshar‐Oromieh, A. (2019) · Immunotherapy · doi:10.2217/imt-2019-0146 · Cited by 5
Environmental geochemistry of radionuclides (Environmental radiochemistry)
Takahashi, Y., Yamaguchi, A., & Yomogida, T. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99762-1.00075-9 · Cited by 5
Design of a 40 MeV superconducting electron linear accelerator for medical isotope production
Chen, K., Hou, H., Liu, Z., Gu, D., & Deng, H. (2025) · Journal of Instrumentation · doi:10.1088/1748-0221/20/04/t04005 · Cited by 4
Radiolabeled Antibodies for Cancer Radioimmunotherapy
Rousseau, J., Lau, J., & Bénard, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-81261-4_14 · Cited by 4
Nuclear Reactor-Based Production of Medical Radionuclides
Cieszykowska, I., Wojdowska, W., Pawlak, D., & Mikołajczak, R. (2025) · Springer eBooks · doi:10.1007/978-3-031-84632-8_2 · Cited by 3
Polyoxometalate-Assisted Crystallization: A General Strategy Enabling Structural Characterization of Molecular Radium Complexes
Engle, K., Fletcher, L. S., Haas, K., Parker, C. J., Felton, D. E., Cary, S. K., Deblonde, G. J. ‐., White, F. D., & Thiele, N. A. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c02763 · Cited by 6
Production of medical radioisotopes via photonuclear reactions: review of candidates and opportunities for the planned radioactive ion facility at IFIN-HH
SCHUBERT, H., Leonte, R. A., Băruță, S., Negoita, F., & Niculae, D. (2024) · Romanian Reports in Physics · doi:10.59277/romrepphys.2024.76.203 · Cited by 3
Measurement of the Th230(p,2n)Pa229 and Th230(p,3n)Pa228 reaction cross sections from 14.1 to 16.9 MeV
Kmak, K. N., Shaughnessy, D. A., & Vujic, J. L. (2021) · Physical Review C · doi:10.1103/physrevc.103.034610 · Cited by 3
Synthesis and Stability Studies of 225Actinium Tin Colloid Radiopharmaceutical
Cakici, D., & Kılbaş, B. (2022) · Advances in Nanoparticles · doi:10.4236/anp.2022.111003 · Cited by 3
The Production of Therapeutic Radionuclides
Cingoranelli, S. J., & Lapi, S. E. (2023) · Springer eBooks · doi:10.1007/978-3-031-39005-0_4 · Cited by 3
The Emerging Potential of Lead-212 Theranostics
Plichta, K. A., & Buatti, J. M. (2025) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2024.11.001 · Cited by 3
Development of Ultracold Francium Atomic Sources Towards the Permanent EDM Search
Hayamizu, T., Haba, H., Nakamura, K., Aoki, T., Nagahama, H., Tanaka, K. S., Ozawa, N., Ohtsuka, M., & Sakemi, Y. (2021) · Few-Body Systems · doi:10.1007/s00601-021-01710-4 · Cited by 3
Concept validation of separations for thorium-based radionuclide generator systems for medical application
Schacherl, B., Maurer, K., Schäfer, M. K.-H., Remde, Y., Geyer, F., Fried, A., Happel, S., & Benešová, M. (2024) · Frontiers in Nuclear Engineering · doi:10.3389/fnuen.2024.1379996 · Cited by 2
Coordination Confinement on the Decay Chains of Typical Medical α-Radionuclides
Qiu, L., Shi, S., He, L., Lyu, J., Tan, F., Chen, X., Hou, R., Liao, J., Yang, Y., Liu, N., et al. (2025) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.5c02195 · Cited by 2
Modeling the yields of 225 Ra/ 225 Ac and the resulting 225 Ac radioisotopic purity from proton irradiation of 232 Th at 100–800 MeV
Jang, J. S., Radchenko, V., Miao, Q., Wada, Y., Schaffer, P. C., & Hoehr, C. (2026) · Physics in Medicine and Biology · doi:10.1088/1361-6560/ae3659 · Cited by 2
Self-citation
Mesothelin-targeted alpha therapy in PDAC with [225Ac]Ac-Macropa-PEG6-Amatuximab
Shah, S. S. H., Santos‐Oliveira, R., Shabnam, M., & DeryaIlem-Ozdemir (2026) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2026.109606 · Cited by 2
High-energy resolution X-ray spectroscopy reveals bonding characteristics of La3+ homologues of actinium radiopharmaceuticals
Ramanantoanina, H., Schacherl, B., Kovács, A., Tagliavini, M., Reynolds, E. M., Reitz, C. Y., Ekanayake, R. S. K., Schäfer, M. K.-H., von Massow, P.-V., Göttlicher, J., et al. (2026) · Communications Chemistry · doi:10.1038/s42004-026-01929-4 · Cited by 2
Semi-Permanent Mass Production of Ac-225 for Cancer Therapy by the (3n,x) Reaction in Pressurized Water Reactor
Iwahashi, D., Sasaki, Y., Shinohara, T., & Takaki, N. (2023) · Processes · doi:10.3390/pr12010083 · Cited by 2
Effect of 226Ra purity as a target for 225Ac production using a fast reactor
Sasaki, Y., & Maeda, S. (2024) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-024-09397-7 · Cited by 2
State of the art and future perspectives of new radionuclides in Nuclear Medicine. Part II
Sancho, L., Roteta, A., Torres, I., de Arcocha, M., Ramos-Membrive, R., Domínguez, M. L., Rosales, J. J., Prieto, E., & Quincoces, G. (2025) · Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) · doi:10.1016/j.remnie.2025.500128 · Cited by 2
Characterizing secondary neutrons at BLIP for isotope production applications
Lin, W., Skulski, M., Cutler, C. S., Medvedev, D., & Morrell, J. (2025) · Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms · doi:10.1016/j.nimb.2025.165815 · Cited by 2
Delivery of radiopharmaceuticals and theranostic agents: targeted alpha therapy
Chatterjee, S., Czerwinski, K. R., Fitzgerald, H. A., Lakes, A. L., Liao, Z., Ludwig, R. C., McBride, K. M., & Vlasenko, V. P. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91376-8.00012-4 · Cited by 2
Production of Radionuclides
Vallabhajosula, S. (2023) · Springer eBooks · doi:10.1007/978-3-031-23205-3_8 · Cited by 2
Production of neptunium and plutonium nuclides from uranium carbide using 1.4-GeV protons
Au, M., Athanasakis-Kaklamanakis, M., Nies, L., Heinke, R., Chrysalidis, K., Köster, U., Kunz, P., Marsh, B. A., Mougeot, M., Schweikhard, L., et al. (2023) · Physical Review C · doi:10.1103/physrevc.107.064604 · Cited by 2
Systematic study of thin barium/radium target production using electroplating method
Jajčišinová, E., Kellerbauer, A., Burdeinyi, D. D., Carrapiço, C., & Malmbeck, R. (2025) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2025.112082 · Cited by 1
Theoretical optimal 232 Th target thicknesses for 225 Ac production at proton energies of 70–200 MeV
Jang, J. S., Schaffer, P. C., Radchenko, V., Moskven, L., Akimitsu, N., Wada, Y., & Hoehr, C. (2025) · Physics in Medicine and Biology · doi:10.1088/1361-6560/adfcae · Cited by 1
Self-citation
Simulation study of medical isotope production by accelerator induced reactions
Liang, Q., Lai, T., Zhang, X., & Yang, G. (2025) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2025.112189 · Cited by 1
A composite target of a radium salt and a soft metal matrix for production of Ac-225 with a proton or electron accelerator
Diamond, W. T., Ross, C. K., & Moore, H. A. (2025) · Journal of Applied Physics · doi:10.1063/5.0294695 · Cited by 1
Assessing the imaging calibration factor for quantitative SPECT/CT of actinium-225
Tulik, M., Krzemiński, J., Pawlak, D., Bruchertseifer, F., Chilug, L., Baran, J. M., & Kunikowska, J. (2026) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2026.112773 · Cited by 1
A study of 225Ac production cross section by proton, deuteron, and neutron irradiation on 232Th targets based on FLUKA and PHITS toolkit
Zhu, K.-Y., Yan, K.-J., Zhang, G.-L., Zhang, W., Cheng, C. X., Xu, X., Huang, Z., & Qu, W.-W. (2026) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2026.112487 · Cited by 1
Radionuclide‑drug conjugates in lung cancer: advances in precision therapy and clinical translation
Liu, J., Zuo, X., Yang, X., Wang, X., Gan, L., & Xue, J. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02695-6 · Cited by 1
Heat-flux-matched adaptive design and thermo-hydraulic performance analysis of microchannel cooling for non-uniform heat flux distributions
Zheng, L., Zhao, J., Zhang, Y., Dong, J., 陶, K. 科. T., Fu, F., Zhang, H., & Yang, L. (2026) · Applied Thermal Engineering · doi:10.1016/j.applthermaleng.2026.132100 · Cited by 1
Local Production of the Alpha-Emitting Radioi-sotope Actinium 225 with Low Impurities for Targeted Alpha Ther-apy by a Compact Neutron Generator System
Martellini, M., Leung, K. N., Gherardi, G., & Falzone, L. (2023) · Medical Research Archives · doi:10.18103/mra.v11i9.4409 · Cited by 1
Status of the 226 Ra nuclear data library and its impact on the production amount of 225 Ac via the 226 Ra (n,2n) reaction
Sasaki, Y., Iwamoto, N., Takaki, N., & Maeda, S. (2023) · Journal of Nuclear Science and Technology · doi:10.1080/00223131.2023.2295018 · Cited by 1
225Ac production via 226Ra (μ−, n ν) 225Fr reaction with 226Ra target
Matsuzaki, T., & SAKURAI, H. (2024) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-024-09514-6 · Cited by 1
Prostaatspecifiek membraanantigeen radioligandtherapie met alfastralers, een review
Privé, B. M., van Gemert, W. A., Nagarajah, J., Mehra, N., Gerritsen, W. R., van Oort, I. M., Gotthardt, M., Heskamp, S., & Janssen, M. J. R. (2020) · Tijdschrift voor Urologie · doi:10.1007/s13629-020-00301-y · Cited by 1
Production of Therapeutic Radionuclides
Loveless, C. S., & Lapi, S. E. (2020) · doi:10.1002/9781119500575.ch5 · Cited by 1
Concepts and Issues for Therapeutic Radiopharmaceuticals
Sowa, A. R., & Scott, P. J. H. (2020) · doi:10.1002/9781119500575.ch2 · Cited by 1
A Digital Twin to Optimize Treatment Efficacy of Targeted Alpha-particle Therapies by Antibody-Radioconjugate Cocktails Against Solid TumorsPreprint
Kavousanakis, M. E., Macher, R., Kevrekidis, Y., & Sofou, S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.19.695379 · Cited by 1
Rationale for Translational Research on Targeted Alpha Therapy in Japan —Renaissance of Radiopharmaceuticals Utilizing Astatine-211 and Actinium-225—
Yano, T., Hasegawa, K., Sato, T., Tatsumi, M., Watabe, T., Kadonaga, Y., Kabayama, K., Fukase, K., Hachisuka, A., Hirabayashi, Y., et al. (2020) · RADIOISOTOPES · doi:10.3769/radioisotopes.69.329
Production of neptunium and plutonium nuclides from uranium carbide using 1.4-GeV protonsPreprint
Au, M., Athanasakis-Kaklamanakis, M., Nies, L., Heinke, R., Chrysalidis, K., Köster, U., Kunz, P., Marsh, B. A., Mougeot, M., Schweikhard, L., et al. (2023) · arXiv (Cornell University) · doi:10.48550/arxiv.2303.12226
Feasibility of Preclinical 225Ac imaging in commercial and a developmental gamma camera
Encarnação, P. M. C. C., Correia, P. M. M., Du, S., Veloso, J. F. C. A., Seo, Y., & Rodríguez, J. C. (2023) · IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) · doi:10.1109/nssmicrtsd49126.2023.10338282
Theranostics in prostaatkanker
Privé, B. M., Muselaers, S., Peters, S. M. B., Timmermans, B. J. R., Westdorp, H., Franken, M. D., Vis, A. N., Janssen, M. J. R., Oprea‐Lager, D. E., & Nagarajah, J. (2024) · Tijdschrift voor Urologie · doi:10.1007/s13629-024-00423-7
Program for Determining the Dosimetric Contribution of Tc-99m Biokinetics in Estimating the Dose to the Heart of a Male Adult
Morales-Nizama, R. A., Gallozzo-Cárdenas, M., Chinchay-Espino, H., Murga-Torres, E. E., Alvarez-Escobedo, A. M., & Nazario-Naveda, R. (2024) · Journal of Medical Physics · doi:10.4103/jmp.jmp_79_23
In-vivo imaging of therapeutic radiopharmaceuticals with a developmental CZT-based SPECT
Encarnação, P. M. C. C., Correia, P. M. M., Rodríguez, J. C., Veloso, J. F. C. A., & Seo, Y. (2024) · IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC) · doi:10.1109/nss/mic/rtsd57108.2024.10655999
Comparison of [125I]I-labeled trastuzumab and pertuzumab for targeted Auger electron therapy of cancers overexpressing HER2 receptors
Nosrati, S., Majka, E., Łyczko, M., Walczak, R., Majkowska‐Pilip, A., & Bilewicz, A. (2024) · Bio-Algorithms and Med-Systems · doi:10.5604/01.3001.0054.9271
Efficiency of carbothermal reduction in treating NORM waste containing Ba(226Ra)SO4
Zhang, L., Lu, Z., Su, Z. A., Zhang, Y., & He, H. (2025) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-024-09935-3
Mechanics and Heat Transfer Design of Thorium Metal Target Protection Thin Film in Isotope Production in Gansu Province
Liu, Y., Zhang, J., Liu, W., Ma, L., Wang, M., Zhang, Y., Yang, L., & Yang, Y. (2025) · Energies · doi:10.3390/en18040928
Estado del arte y perspectivas futuras de nuevos radionúclidos en Medicina Nuclear: Parte II
Sancho, L., Roteta, A., Torres, I., de Arcocha, M., Ramos-Membrive, R., Domínguez, M. L., Rosales, J. J., Prieto, E., & Quincoces, G. (2025) · Revista Española de Medicina Nuclear e Imagen Molecular · doi:10.1016/j.remn.2025.500128
Radioisotope-labeled tyrosine kinase inhibitors in the diagnosis and treatment of lung cancer
Zahid, M., Wang, H., Li, Y., & Zhang, J. (2025) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-025-10295-9
Feasibility study on the production of 229 Th as a long-life 225 Ac generator using the experimental fast reactor Joyo
Sasaki, Y., Maeda, S., Fukasawa, T., & Takaki, N. (2025) · Journal of Nuclear Science and Technology · doi:10.1080/00223131.2025.2558244
A study of 225Ac production cross section by proton, deuteron, and neutron irradiation on 232Th targets based on FLUKA toolkitPreprint
Zhu, K. Y., Zhang, G., Zhang, W., Chang, C. K., Xu, X., Huang, Z., & Qu, W. W. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5549541
Recent evidence of theranostics and its perspectives on clinical advances and emerging approaches
Rawal, K. B., Kolte, K., Chand, S., Sutar, A. S., & Singh, R. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-34199-1.00004-1
Radium-228 target fabrication after separation from thorium-232 by polyvinylpolypyrrolidone for radiopharmaceutical actinium-225 production
Yin, F., YAMAMURA, T., & Suzuki, T. (2025) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-025-10406-6
Additional file 1 of A suitable time point for quantifying the radiochemical purity of 225Ac-labeled radiopharmaceuticals
Kelly, J. M., Amor‐Coarasa, A., Sweeney, E., Wilson, J. J., Causey, P. W., & Babich, J. W. (2021) · Figshare · doi:10.6084/m9.figshare.17305293
Additional file 1 of Production, purification, and radiolabeling of the 203Pb/212Pb theranostic pair
McNeil, B. L., Robertson, A. K. H., Fu, W., Yang, H., Hoehr, C., Ramogida, C. F., & Schaffer, P. (2021) · Figshare · doi:10.6084/m9.figshare.13684769
Self-citation
Monte Carlo simulation of medical isotopes production by irradiation of nat U and 232 Th targets with p, α, 9 Be and 12 CPreprint
Liang, Q., & Zhang, X.-C. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5554666
Sintering characteristics of ThO2 with different powder morphologies
Gubbels, L., Ramos, J. P., Vleugels, J., Verwerft, M., Popescu, L., & Acevedo, B. (2025) · Journal of Nuclear Materials · doi:10.1016/j.jnucmat.2025.156415
Demonstration of a 228Ra/228Ac isotope generator
Kmak, K. N., Despotopulos, J. D., & Huynh, T. L. (2026) · Journal of Chromatography A · doi:10.1016/j.chroma.2026.466837
Attempts to Improve the In vivo Stability of At-211 Labeled Agents
Suzuki, H. (2026) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.25-00146-2
Quantitative carboxyl functional activated carbon for efficient separation of Th and La (Ac)
Zhou, S., Jiang, C., Wang, Q., Ding, M., Jin, Y., & Xia, C. (2026) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-026-10967-0
Separation of radium and actinium in acetic acid/acetate solutions using TK101 resin
Kmak, K. N., Despotopulos, J. D., Coupannec, M., & Huynh, T. L. (2026) · Journal of Chromatography A · doi:10.1016/j.chroma.2026.467172
Effect of dispersive and relativistic optical model potentials on the production cross-section calculation of 225Ac from 232Th using proton energy
Ige, O. O., Longmena, T. S., & Jonah, S. A. (2026) · Nuclear Energy and Technology · doi:10.3897/nucet.12.178562
Purification of Actinium-225 from Thorium via Selective Precipitation
Schultz, S. J., Adelman, S. L., Dutech, G., Fassbender, M. E., Henning, C. D., Long, B. N., Pace, K. A., Kozimor, S. A., Mocko, V., & Shaw, T. E. (2026) · Molecules · doi:10.3390/molecules31122144 · Cited by 1
Ra-226 extraction and purification from simulated uranium tailings
Coupannec, M., Kmak, K. N., & Despotopulos, J. D. (2026) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-026-11005-9
Perspective on production of radioisotopes via nuclear fusion reactors
McCarthy, T., Johnston, R., Brand, M. I., Pascali, G., & Burr, P. A. (2026) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2026.109673
Monte Carlo Simulation of Medical Isotopes Production by Irradiation of nat U and 232 Th Targets with P, α, 9 Be and 12 C
Liang, Q., Lai, T., Yang, G., Yang, Q., Fu, F., & Zhang, X. (2026) · Nuclear Science and Engineering · doi:10.1080/00295639.2026.2707586
Accelerator tuning via model-coupled optics and Bayesian steering
Hassan, O., Shelbaya, O., Jung, P. M., Kester, O., Planche, T., & Fedorko, W. T. (2026) · Physical Review Accelerators and Beams · doi:10.1103/1vy9-r7c6

Authors: Robertson, A. K. H., Ramogida, C. F., Schaffer, P., & Radchenko, V.
Affiliations: TRIUMF (CA)
Corresponding author: Radchenko, Valery
ORCID: Robertson, Andrew Kyle Henderson
Ramogida, Caterina Fortunata
Schaffer, Paul
Radchenko, Valery
Venue: Current Radiopharmaceuticals
Publisher: Bentham Science Publishers Ltd.
Published: 2018-10-22
Volume: 11
Issue: 3
Pages: 156-172
ISSN: 1874-4710 (ISSN-L)
DOI: 10.2174/1874471011666180416161908
PMC: PMC6249690
OpenAlex: W2801430183
Cited by: 202
References: 59
Citations by year: 2026: 23 · 2025: 35 · 2024: 34 · 2023: 24 · 2022: 22 · 2021: 29 · 2020: 26 · 2019: 8 · 2018: 1
FWCI: 11.05
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: cc-by-nc
Locations: Current Radiopharmaceuticals (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
PubMed Central (publishedVersion, cc-by-nc)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Chemical Reactions and Isotopes
Physical Sciences › Physics and Astronomy › Radiation › Radioactivity and Radon Measurements
Keywords: actinium-225, radiopharmaceuticals, targeted alpha therapy, TRIUMF, isotope separation, radiolabeling yield, alpha-emitting radionuclides
MeSH terms: Actinium, Alpha Particles, Humans, Neoplasms, Radiochemistry, Radionuclide Generators, Radiopharmaceuticals

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks